Considerations for Management of Bupivacaine Formulation Shortage Affecting Obstetric Anesthesia Services.
Healthcare facilities across North America are experiencing a shortage of several formulations of bupivacaine affecting analgesia and anesthesia care, particularly for obstetric services. This editorial will discuss evidence-based considerations to address the bupivacaine shortage including interprofessional team engagement for planning, alternative anesthetic and analgesic management strategies for the obstetrical patient, and safe drug preparation. As leaders in healthcare, nurse anesthetists are encouraged to work closely with their anesthesia, pharmacy, obstetric, and facility leadership to develop best alternative solutions during this drug shortage to provide safe analgesic and anesthetic care.
['Kasson|Brian|B|', 'Hledin|Victoria|V|', 'Clayton|Beth|B|', 'Pellegrini|Joseph|J|', 'Reede|Lynn|L|']
D000773:Anesthesia, Obstetrical D000779:Anesthetics, Local D002045:Bupivacaine D005260:Female D006801:Humans D009719:Nurse Anesthetists D059408:Pain Management D011247:Pregnancy D014481:United States
obstetric anesthesia Bupivacaine shortage drug shortage